ResearcherPage View Count

Geo Map
Region#
AS - Asia5757
NA - North America2309
HKU - The University of Hong Kong2145
EU - Europe1577
OC - Oceania27
AF - Africa21
SA - South America12
UND - Undefined93
Total11941
Country#
CN - China3886
US - United States2261
HKU - The University of Hong Kong2145
HK - Hong Kong831
KR - Republic of Korea752
GB - United Kingdom723
FR - France302
IE - Ireland155
NL - Netherlands120
RU - Russia71
OTH - Others695
Total11941
City#
The University of Hong Kong2145
Ashburn1160
Shenzhen508
Beijing447
Central District332
Zhengzhou275
Fairfield215
Wuhan175
Shanghai161
Dublin149
Others6374
Total11941
A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer106
Chemotherapy with or without maintenance sunitinib for untreated extensive-stage small cell lung cancer: A randomized, placebo controlled phase II study CALGB 30504 (ALLIANCE)112
Determinants of physical, mental and social well-being: a longitudinal environment-wide association study12
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors77
VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)95
Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus74
Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial95
Interim analysis of CALGB 150607: A pilot study of the mutational & expression status of MET, HGF, EGFR, KRAS, p53, c-CBL, and E-cadherin in resected lung adenocarcinoma specimens90
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab65
Next-Generation Sequencing with a 54-Gene Panel Identifies Unique Mutational Profile and Prognostic Markers in Chinese Patients with Myelofibrosis112
Clinical prognostic model for older patients with advanced non-small cell lung cancer13
Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer109
A leave-one-out cross-validation SAS macro for the identification of markers associated with survival106
Diffusion-weighted magnetic resonance imaging of primary cervical cancer in the detection of sub-centimetre metastatic lymph nodes7
Therapy for chemotherapy-induced peripheral neuropathy - In reply79
Change in moderate alcohol consumption and quality of life: evidence from 2 population-based cohorts47
Random Effects Model for Multiple Pathway Analysis with Applications to Type II Diabetes Microarray Data80
Combination chemotherapy with sunitinib (IND 74019; NSC 736511) for untreated extensive-stage small cell lung cancer (SCLC): CALGB 30504 phase IB safety results80
Reporting and guidelines for mendelian randomization analysis: A systematic review of oncological studies10
High-dimensional association study of lifestyle and behavioural factors with survival outcome in the Guangzhou Biobank Cohort Study (GBCS)94
Validation of the CALGB and EORTC Prognostic Models for Mesothelioma based on multiple CALGB Trials (Alliance)79
Gender and Menopause Impact Severity of Fibrosis among Patients with Nonalcoholic Steatohepatitis64
Reply56
Modulation of angiogenic biomarkers in patients treated on a phase I study of TRC105 (anti-CD105 antibody) monotherapy for advanced solid tumors64
A comparison of graph- and kernel-based –omics data integration algorithms for classifying complex traits78
Analysing breast cancer microarrays from African Americans using shrinkage-based discriminant analysis77
Modest alcohol consumption attenuates expression of fibrosis-associated genes in patients with non-alcoholic fatty liver Disease (NAFLD)68
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups64
Bayesian Semiparametric Model for Pathway-Based Analysis with Zero-Inflated Clinical Outcomes8
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis73
Machine learning interpretation of extended human papillomavirus genotyping by Onclarity in an Asian cervical cancer screening population19
Modulation of angiogenic biomarkers in patients receiving high-dose TRC10573
CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM)64
Statistical properties on semiparametric regression for evaluating pathway effects82
Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non–Small Cell Lung Cancer8
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation17
Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC41
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 17060148
Composition of gut microbiota in infants in China and global comparison78
Here's to Your Health: Building and Validating High Throughput Lung Cancer Biomarkers47
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations40
Coffee consumption increases hepatic expression of cytochrome P450S and significantly reduces liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD)96
What family-based factors are associated with happiness? A multi-level high-dimensional association study of the FAMILY Cohort9
Normative data and psychometric properties of the Connor–Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong Kong123
A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer14
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 3020671
Diabetes incidence and prevalence in Hong Kong during 2007-1350
Cohort Profile: FAMILY Cohort163
Optimal Nearest Shrunken Centroids Method for High-dimensional Data Classification61
Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer7
Transmissibility of the Ice Bucket Challenge among globally influential celebrities: retrospective cohort study72
13 Pathway. Based Methods for Analyzing Microarray Data136
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance)71
Transmissibility of the Ice Bucket Challenge among globally influential celebrities: retrospective cohort study142
A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance11
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 201289
Systematic evaluation of factors associated with health-related quality of life: a high-dimensional multivariate multilevel analysis in the FAMILY Cohort16
Relationship type, condom use and HIV/AIDS risks among men who have sex with men in six Chinese cities229
Normative data and psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong Kong38
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited‐stage small cell lung cancer in elderly patients versus younger patients21
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease82
Endpoints for Cancer Clinical Trials48
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors78
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial98
Pathway-based identification of SNPs predictive of survival67
Stratified Pathway Analysis to Identify Gene Sets Associated with Oral Contraceptive Use and Breast Cancer45
Bacteriophage of the Skin Microbiome in Patients with Psoriasis and Healthy Family Controls41
Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A)61
Bias-adjusted Kaplan–Meier survival curves for marginal treatment effect in observational studies20
Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status42
An Interim Report Of CALGB 150607: Expression And Mutational Status Of c-MET, HGF, EGFR, KRAS, p53, c-CBL, And E-cadherin In Resected Lung Adenocarcinoma Specimens100
Impact of Gender and Menopause on Histologic Severity of Inflammation and Injury in patients with Nonalcoholic Fatty Liver Disease76
Methodological Considerations in the Design and Implementation of Clinical Trials70
Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study93
Shrinkage-based diagonal Hotelling’s tests for high-dimensional small sample size data42
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients81
Bayesian semiparametric regression models for evaluating pathway effects on continuous and binary clinical outcomes108
Pathway-based Single-Cell RNA-Seq Classification, Clustering, and Construction of Gene-Gene Interactions Networks Using Random Forests7
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer91
Comparison of chemoradiotherapy treatment strategies in stage III non-small cell lung cancer among elderly patients from multiple data sources54
Association of an Early Intervention Service for Psychosis With Suicide Rate Among Patients With First-Episode Schizophrenia-Spectrum Disorders132
Expression QTL analysis of a gene expression signature which predicts advanced non-alcoholic fatty liver disease95
Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes97
Predictors of pulmonary toxicity in limited-stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high-dose (70 Gy) daily radiotherapy (RT): a pooled analysis of three CALGB studies92
Building pathway clusters from Random Forests classification using class votes73
Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non–Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies19
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report85
Diabetes incidence and prevalence in Hong Kong, China during 2006-2014223
Direct participation in and indirect exposure to the occupy central movement and depressive symptoms: a longitudinal study of Hong Kong adults104
Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE)90
Statistical aspect of translational and correlative studies in clinical trials44
Epigenetic Regulation of Gene Expression in NAFLD111
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)80
Pathway analysis using random forests with bivariate node-split for survival outcomes.88
A retrospective study on amiodarone pulmonary toxicity in Chinese patients in Hong Kong16
Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors64
Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70Gy daily radiotherapy: CALGB 3090480
Inter-session reproducibility and consistency of radiomic features after preprocessing as methods for quality control in MRI quantitative radiomics94
Coffee's beneficial effect on liver disease confirmed in NASH cohort, but only partially confirmation of in vitro pre-described differentially expressed genes in this patient cohort75
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: A re-analysis of meta-analyses of individual patients' data111
Pathway analysis using random forests classification and regression114
Effect of machine learning re-sampling techniques for imbalanced datasets in 18F-FDG PET-based radiomics model on prognostication performance in cohorts of head and neck cancer patients8
Correlation of Src activation with response to dasatinib, capecitabine, oxaliplatin, and bevacizumab in advanced solid tumors60
A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904108
Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease115
CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)149
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)95
Conserved gene expression patterns in myofibroblastic murine and human hepatic stellate cells and nafld patients with liver fibrosis compatible with epithelial-to-mesenchymal like transition96
Block-diagonal discriminant analysis and its bias-corrected rules115
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas113
Statistical Analysis of Biomarkers from Omics Technologies96
Gene selection using iterative feature elimination random forests for survival outcomes82
Shrinkage-based diagonal discriminant analysis and its applications in high-dimensional data87
Short-term and long-term outcomes for video-assisted thoracoscopic surgery and open lobectomy: Results from statistical analysis adjusting for treatment selection bias45
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis65
Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease105
Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials29
Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis19
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304)87
Pathway-based meta-analysis for partially paired transcriptomics analysis10
Determinants of a subject's decision to participate in clinical anesthesia research122
Preventing respiratory tract infections by synbiotic interventions: a systematic review and meta-analysis of randomized controlled trials9
Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data59
A Phase II study of dasatinib in patients with chemo-sensitive relapsed small cell lung cancer (SCLC): CALGB 3060251
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors78
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer85
A metagenomics study of the elbow of psoriasis subjects and their healthy relatives96
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602)104
Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures14
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer96
A phase II study of sorafenib in malignant mesothelioma: Results of Cancer and Leukemia Group B 30307148
Seamless Phase IIa/IIb and enhanced dose-finding adaptive design4
A randomized factorial design to examine the effect of requesting Hong Kong identity card (HKID) numbers and participation incentives on participant’s consent to health record linkage: evidence from the FAMILY Cohort28
Direct Evidence of Targeted Inhibition by Anti-angiogenic Agents from a Wound-healing Model in Patients with Advance Solid Tumors98
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)6
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)69
Impact of patient education on influenza vaccine uptake among community-dwelling elderly: a randomized controlled trial80
Longitudinal Predictors of Depression Trajectories following a Major Protest52
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC1057
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 8030368
Radiomics Model to Predict Early Progression of Nonmetastatic Nasopharyngeal Carcinoma after Intensity Modulation Radiation Therapy: A Multicenter Study36
Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies164
A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. Cooperative Group Trials: comparing the outcomes of elderly to younger patients (pts)101
Longitudinal patterns and predictors of depression trajectories related to the 2014 occupy central/umbrella movement in Hong Kong123
Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidism1187
Ten-year employment patterns of patients with first-episode schizophrenia-spectrum disorders: comparison of early intervention and standard care services26
Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis93
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer96
Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing67
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups69


TotJulAugSepOctNovDecJanFebMarAprMayJun
2014/20151054967849231422721394280423160
2015/20163330332710832521265525613143560296
2016/2017120211560531541384958667716219872
2017/201814988316468204126239304918912714475
2018/20192548177109137150163223199134153285504314
2019/202023092252491581621812013581832301592030
Ever11941